The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Beijing Aosaikang Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.72% CNY11.10
America/New_York / 6 mai 2024 @ 00:47
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 10 303 mill |
| EPS: | -0.0600 |
| P/E: | -185.00 |
| Earnings Date: | May 29, 2024 |
| SharesOutstanding: | 928.16 mill |
| Avg Daily Volume: | 6.70 mill |
| RATING 2024-05-06 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -185.00 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -4.06x |
| Company: PE -185.00 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY1.206 (-89.13%) CNY-9.89 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 10.61 - 11.59 ( +/- 4.43%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY11.10 (-0.72% ) |
| Volume | 6.63 mill |
| Avg. Vol. | 6.70 mill |
| % of Avg. Vol | 98.96 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002755.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002755.SZ
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.